1,144
Views
15
CrossRef citations to date
0
Altmetric
Research Paper

Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines

, , , , &
Pages 397-406 | Received 14 Jul 2018, Accepted 09 Sep 2018, Published online: 12 Oct 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sayumi Yoshida, Zensho Ito, Machi Suka, Tsuuse Bito, Shin Kan, Takafumi Akasu, Masayuki Saruta, Masato Okamoto, Hiroaki Kitamura, Shuichi Fujioka, Takeyuki Misawa, Tadashi Akiba, Hiroyuki Yanagisawa, Haruo Sugiyama & Shigeo Koido. (2019) Clinical Significance of Tumor-Infiltrating T Cells and Programed Death Ligand-1 in Patients with Pancreatic Cancer. Cancer Investigation 37:9, pages 463-477.
Read now

Articles from other publishers (14)

Hisashi Nagai & Ryusuke Karube. (2023) Delayed-Type Hypersensitivity: An Excellent Indicator of Anti-tumor Immunity With Wilms' Tumor 1 (WT1) Dendritic Cell Vaccine Therapy. Cureus.
Crossref
Hisashi Nagai & Ryusuke Karube. (2023) WT1 Dendritic Cell Vaccine Therapy Improves Immune Profile and Prolongs Progression-Free Survival in End-Stage Lung Cancer. Cureus.
Crossref
Melanie Herpels, Jun Ishihara & Anguraj Sadanandam. (2023) The clinical terrain of immunotherapies in heterogeneous pancreatic cancer: unravelling challenges and opportunities. The Journal of Pathology.
Crossref
Yunchao Zhang, Chenxin Liu, Chunjie Wu & Linjiang Song. (2023) Natural peptides for immunological regulation in cancer therapy: Mechanism, facts and perspectives. Biomedicine & Pharmacotherapy 159, pages 114257.
Crossref
Yusuke Oji, Naoki Kagawa, Hideyuki Arita, Norifumi Naka, Ken-ichiro Hamada, Hidetatsu Outani, Yasushi Shintani, Yoshito Takeda, Eiichi Morii, Kenzo Shimazu, Motoyuki Suzuki, Sumiyuki Nishida, Jun Nakata, Akihiro Tsuboi, Miki Iwai, Sae Hayashi, Rin Imanishi, Sayaka Ikejima, Mizuki Kanegae, Masahiro Iwamoto, Mayu Ikeda, Kento Yagi, Haruka Shimokado, Hiroko Nakajima, Kana Hasegawa, Soyoko Morimoto, Fumihiro Fujiki, Akira Nagahara, Atsushi Tanemura, Yutaka Ueda, Tsunekazu Mizushima, Masato Ohmi, Takayuki Ishida, Manabu Fujimoto, Norio Nonomura, Tadashi Kimura, Hidenori Inohara, Seiji Okada, Haruhiko Kishima, Naoki Hosen, Atsushi Kumanogoh, Yoshihiro Oka & Haruo Sugiyama. (2023) WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1. Cancers 15:2, pages 393.
Crossref
Zachary P. Yeung & Madappa N. Kundranda. 2023. Pancreatic Cancer. Pancreatic Cancer 97 146 .
Jasmeet Dhaliwal. (2022) Exploring the Therapeutic Opportunities of the Tumour Microenvironment in Treating Pancreatic Ductal Adenocarcinoma: A Literature Review. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal 6:11, pages 1-9.
Crossref
Nicole Wagner & Kay-Dietrich Wagner. (2022) Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer. Cells 11:15, pages 2432.
Crossref
Qing Zhang, Dan Hou, Xueying Wen, Mengyu Xin, Ziling Li, Lihong Wu & Janak L. Pathak. (2022) Gold nanomaterials for oral cancer diagnosis and therapy: Advances, challenges, and prospects. Materials Today Bio 15, pages 100333.
Crossref
Chao Yin, Ali Alqahtani & Marcus S. Noel. (2022) The Next Frontier in Pancreatic Cancer: Targeting the Tumor Immune Milieu and Molecular Pathways. Cancers 14:11, pages 2619.
Crossref
Florentine E. F. Timmer, Bart Geboers, Sanne Nieuwenhuizen, Madelon Dijkstra, Evelien A. C. Schouten, Robbert S. Puijk, Jan J. J. de Vries, M. Petrousjka van den Tol, Anna M. E. Bruynzeel, Mirte M. Streppel, Johanna W. Wilmink, Hans J. van der Vliet, Martijn R. Meijerink, Hester J. Scheffer & Tanja D. de Gruijl. (2021) Pancreatic Cancer and Immunotherapy: A Clinical Overview. Cancers 13:16, pages 4138.
Crossref
Michael A. Morse, William R. GwinIIIIII & Duane A. Mitchell. (2021) Vaccine Therapies for Cancer: Then and Now. Targeted Oncology 16:2, pages 121-152.
Crossref
Kyaw Zaw Hein, Shuyang Yao & Siqing Fu. (2020) Wilms' Tumor 1 (WT1): The Vaccine for Cancer. Journal of Immunotherapy and Precision Oncology 3:4, pages 165-171.
Crossref
Shailendra K. Gautam, Sushil Kumar, Vi Dam, Dario Ghersi, Maneesh Jain & Surinder K. Batra. (2020) MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy. Seminars in Immunology 47, pages 101391.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.